Entity Common Stock, Shares Outstanding of Sunshine Biopharma Inc. from 09 Aug 2011 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sunshine Biopharma Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Aug 2011 to 13 Nov 2025.
  • Sunshine Biopharma Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 4,905,945, a 145% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Sunshine Biopharma Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,905,945 +2,906,285 +145% 13 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 4,555,945 -14,389,107 -76% 12 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 2,707,541 -96,745,324 -97% 21 Mar 2025 10-K 01 Apr 2025 2024 FY
Q3 2024 1,999,660 -23,678,630 -92% 05 Nov 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 18,945,052 -6,801,250 -26% 17 May 2024 10-Q 20 May 2024 2024 Q1
Q1 2024 99,452,865 +76,867,233 +340% 28 Mar 2024 10-K 28 Mar 2024 2023 FY
Q3 2023 25,678,290 +3,092,658 +14% 13 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 25,746,302 +6,860,670 +36% 10 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 22,585,632 +15,455,854 +217% 31 Mar 2023 10-K 04 Apr 2023 2022 FY
Q3 2022 22,585,632 -492,757,633 -96% 07 Nov 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 18,885,632 -491,207,633 -96% 03 Aug 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 7,129,778 -457,876,147 -98% 05 Mar 2022 10-K 21 Mar 2022 2021 FY
Q4 2021 0 15 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q3 2021 515,343,265 +182,923,969 +55% 09 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 510,093,265 +397,204,266 +352% 09 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 465,005,925 +395,066,619 +565% 30 Mar 2021 10-K 30 Mar 2021 2020 FY
Q3 2020 332,419,296 -187,711,449 -36% 10 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 112,888,999 +17,471,234 +18% 18 May 2020 10-Q 18 May 2020 2020 Q1
Q1 2020 69,939,306 -19,409,675 -22% 30 Apr 2020 10-K 01 May 2020 2019 FY
Q3 2019 520,130,745 13 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 95,417,765 -873,094,893 -90% 20 May 2019 10-Q 20 May 2019 2019 Q1
Q1 2019 89,348,981 -858,670,551 -91% 11 Apr 2019 10-K 12 Apr 2019 2018 FY
Q4 2018 1,632,980,943 +714,244,445 +78% 15 Nov 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 968,512,658 +50,863,117 +5.5% 21 May 2018 10-Q 22 May 2018 2018 Q1
Q1 2018 948,019,532 +96,091,549 +11% 28 Mar 2018 10-K 02 Apr 2018 2017 FY
Q4 2017 918,736,498 15 Nov 2017 10-Q 15 Nov 2017 2017 Q3
Q2 2017 917,649,541 11 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 851,927,983 +629,051,630 +282% 12 Apr 2017 10-K 17 Apr 2017 2016 FY
Q3 2016 686,399,858 +548,849,866 +399% 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q1 2016 222,876,353 +145,825,312 +189% 24 Mar 2016 10-K 25 Mar 2016 2015 FY
Q3 2015 137,549,992 +68,638,951 +100% 04 Nov 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 129,290,768 +61,019,807 +89% 06 Aug 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 77,051,041 +11,775,313 +18% 09 Mar 2015 10-K 11 Mar 2015 2014 FY
Q3 2014 68,911,041 +6,735,313 +11% 10 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 68,270,961 +11,831,900 +21% 12 Aug 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 65,275,728 +13,509,636 +26% 08 May 2014 10-Q 09 May 2014 2014 Q1
Q3 2013 62,175,728 +10,784,636 +21% 04 Nov 2013 10-K 19 Mar 2014 2013 FY
Q2 2013 56,439,061 +6,346,219 +13% 05 Aug 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 51,766,092 +3,037,250 +6.2% 13 Mar 2013 10-K 15 Mar 2013 2012 FY
Q3 2012 51,391,092 +20,353,750 +66% 07 Nov 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 50,092,842 +19,381,500 +63% 03 Aug 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 48,728,842 15 Mar 2012 10-K 19 Mar 2012 2011 FY
Q3 2011 31,037,342 07 Nov 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 30,711,342 09 Aug 2011 10-Q 09 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.